pre-miRNA Information
pre-miRNA hsa-mir-210   
Genomic Coordinates chr11: 568089 - 568198
Synonyms MIRN210, mir-210, MIR210
Description Homo sapiens miR-210 stem-loop
Comment This human miRNA was predicted by computational methods using conservation with mouse and Fugu rubripes sequences .
RNA Secondary Structure
Associated Diseases

Mature miRNA Information
Mature miRNA hsa-miR-210-3p
Sequence 66| CUGUGCGUGUGACAGCGGCUGA |87
Evidence Experimental
Experiments Cloned
Editing Events in miRNAs
Modification Type Position on miR Chromosome DNA Strand Genomic Position (hg38) List of PMIDs Variant details
A-to-I 12 11 - 568122 25582055 MiREDiBase
A-to-I 14 11 - 568120 26028588 MiREDiBase
C-to-U 1 11 - 568133 26209130 MiREDiBase
SNPs in miRNA
Mutant ID Mutant Position Mutant Source
rs753825152 1 dbSNP
rs759616365 3 dbSNP
rs1247955373 6 dbSNP
rs558661304 9 dbSNP
rs1490451308 13 dbSNP
rs1344162213 14 dbSNP
rs745930382 15 dbSNP
rs1220183952 16 dbSNP
rs1355496181 17 dbSNP
rs1280245998 19 dbSNP
rs781628850 20 dbSNP
rs1241231800 22 dbSNP
Putative Targets

miRNA Expression profile
Human miRNA Tissue Atlas
miRNAs in Extracellular Vesicles
Circulating MicroRNA Expression Profiling
Biomarker Information
Biomarker ID Name Type Discovered From Mode Level Source Testing Methods
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Increase Urine Quantitative real-time reverse transcription PCR
BX0CY6 miR-210 Predictive Biomarker (PRD); Safety Biomarker (SAF) Clinical/Experimental Data Expression Low Blood Reverse transcription-polymerase chain reaction
Gene Information
Gene Symbol EHD2   
Synonyms PAST2
Description EH domain containing 2
Transcript NM_014601   
Expression
Putative miRNA Targets on EHD2
3'UTR of EHD2
(miRNA target sites are highlighted)
>EHD2|NM_014601|3'UTR
   1 GCCGGCCCCCCTCCCATGGCCCTGCTGTGGCTCCCCAGCTCCAGTCGGCTGCACGCACACCCCTGCTCCGGCTCACACAC
  81 GCCCTGCCTGCCCTCCCTGCCCAGCTGTAAGGACCGGGGGTCTCCCTCCTCACTACCGCCAGACACCCCGGTGGAAGCAT
 161 TTAGAGGGGACCACGGGAGGGACAAGGCTTCTCTGTCCGCCCTTCACACCTCCAGCCTCACGTTCACTTAGGCACATCAC
 241 ACACACACTGGCACACGCAGGCATCCATCCATCCGTCATTCATTCAAATATTTATTGAGCACCTACTATGTGCCCAGCCC
 321 TGTTCTAGGCACTGGGCATTACCATAGAGAACAAAATAGACAAATACATCTGCCCTCATGGAAGGTGACGTTCCCAGGAG
 401 AGGGCACCTACACAGTCACGCAAACACACACTAATTCCTGGCAGGGCCCCCAGCCCCTCCCCTGGCTGAGCAGCCCTGTG
 481 GCTGAAATGACTAGCAGATAAACAGACCCCCTTCTGCTCCGCTTCCTCCTGCCCAGCCAGGCAACACCCTCAACCGGCTC
 561 CATCACATCCTCAGGTCTCGGGACCATGGGGGGCTCAGAGGGGAGACACACCTACTGCTTCCTCAGATGGGCCCCTCCGC
 641 AGCCCCTTCCCTTGCTCGGGGAAAGCCCCCAATTCTGCCCACACCCATTTATTTCCTTCCTTCCTTCCTTCTTTTCTTTC
 721 CTTCCTTCCTTCTTTTTTGTTTTTGCCCCCAATTCTGCCCATACCCATTTCTTTCTTTCCTTCCTTCCTTCTTTTTTGTT
 801 TTTGCCCCCAGTTCTGTCCACACCCCTTCCCTTTCCTGTCCTGTCCTTTCTTTCTTTTTTGATAGAATCTTGCTCTGTCG
 881 CCCAGGCTGGAGTGCAGTGGTGAGATCTCAGCTCACTGCAACCTCCACCTCCTGGGTTGAAGTGATTCTCGTGCCTCAGC
 961 CTCCTGAGTAGCTGGGACTGCAGGCACGCGCCACCACGCCCAGCTAATTTTTGTATTTGAGTAGAGACGGGGTTTCACCA
1041 TGTTGGCCAGGCTGGTCTCGAACTCCGCATCTCAGGTGATCTGCTCGCCTTGGCCTCCCAAAGTGATGGGATTACAGGCA
1121 TGAGCCACCGTGCCCGGCTTCACACCCATTTCTTTAAAAAGGATCCCGTAGCAGGCAGAAAAGCCCCTTCCATCCTGCTC
1201 CTCTGATACTGTGCCCCCTTGGAGATATTTCCGTCCTCCACCCACGTGTCTGTGGCTGGAACTGCCCAGCCTGCTCCTGG
1281 CCCCCTGGAAGCCTCCCCACAGCTGGTAATCTGGACTTAAGGATTGCTGGGCCACCGCCTCTCTGCCTACCACCATTCCA
1361 TATTTAAGTGGAGCCCCTACGTAGAAAGGCCCCGGGGCTTTATTTTAGTCTCCTTTTCAGGGATGTCGTGGGCGGGGGAG
1441 GGGGTTCTTGGTGCTACAGCCCTCTCCCCACCCCTAAAGGGACGCCGACGCTGTTTGCTGCCTTCACCACATATTAGTGC
1521 TTGACCCTGGCAGGGGACCCCATGGAAAAGATGGGGAAGAGCAAAATACATGGAGACGACGCACCCTCCAGGATGCTCGC
1601 TGGGATTCCCACGCCCACCACTGTCCCCCACCCCATGGCTGGGAGGGGCCTCTGAACGGAACAGTGTCCCCACAGAGCGA
1681 ATAAAGCCAAGGCTTCTTCCCAAAAAAAAAAAAAAAAAA
Target sites Provided by authors   Predicted by miRanda    DRVs    SNPs    DRVs & SNPs
miRNA-target interactions
(Predicted by miRanda)
ID Duplex structure Position Score MFE
1
miRNA  3' agUCGGCGACAG----UGUGCGUGUc 5'
            |||: | |||    :|||||||| 
Target 5' ccAGCTCCAGTCGGCTGCACGCACAc 3'
35 - 60 162.00 -23.00
2
miRNA  3' aguCG-GCGAC----AGUGUGCGUGUc 5'
             || |||||    || ||||| || 
Target 5' gatGCTCGCTGGGATTCCCACGCCCAc 3'
1592 - 1618 133.00 -16.60
3
miRNA  3' agUCGGCGACAGUGUGCGUGUc 5'
            || | |  |||||| |||| 
Target 5' ttAGGCAC-ATCACACACACAc 3'
228 - 248 131.00 -14.00
DRVs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
COSN20115953 6 COSMIC
COSN17078235 117 COSMIC
COSN28791086 175 COSMIC
COSN7447298 271 COSMIC
COSN19704563 318 COSMIC
COSN19699253 344 COSMIC
COSN30657766 423 COSMIC
COSN30645954 477 COSMIC
COSN28127614 515 COSMIC
COSN30633976 522 COSMIC
COSN20223804 716 COSMIC
COSN28548952 768 COSMIC
COSN14447429 834 COSMIC
COSN8261302 951 COSMIC
COSN31485579 1210 COSMIC
COSN31533064 1305 COSMIC
COSN31482327 1338 COSMIC
COSN1769990 1351 COSMIC
COSN27582246 1370 COSMIC
COSN30159360 1436 COSMIC
COSN31517531 1448 COSMIC
COSN28145120 1541 COSMIC
COSN31513281 1573 COSMIC
COSN28712131 1575 COSMIC
SNPs in gene 3'UTRs
Mutant ID Mutant Position Mutant Source
rs1237437347 2 dbSNP
rs778382915 3 dbSNP
rs3833256 4 dbSNP
rs752828516 4 dbSNP
rs1394982880 5 dbSNP
rs397747084 6 dbSNP
rs543620769 6 dbSNP
rs201321731 7 dbSNP
rs1209588791 8 dbSNP
rs757713303 9 dbSNP
rs1489716003 10 dbSNP
rs1206922771 11 dbSNP
rs779242294 12 dbSNP
rs746420280 14 dbSNP
rs771453609 15 dbSNP
rs1156568962 16 dbSNP
rs775116028 17 dbSNP
rs758737448 25 dbSNP
rs1473108528 26 dbSNP
rs1162692168 27 dbSNP
rs768363550 30 dbSNP
rs1431802961 34 dbSNP
rs1308873202 35 dbSNP
rs1395819052 36 dbSNP
rs776268059 39 dbSNP
rs563211729 42 dbSNP
rs1217633691 44 dbSNP
rs1341560624 46 dbSNP
rs772979222 47 dbSNP
rs762984356 48 dbSNP
rs1344771155 49 dbSNP
rs1248037284 50 dbSNP
rs990491667 54 dbSNP
rs1364776664 55 dbSNP
rs1029231072 56 dbSNP
rs955014042 59 dbSNP
rs1284194286 65 dbSNP
rs574661082 70 dbSNP
rs576852056 71 dbSNP
rs140692689 81 dbSNP
rs375493717 81 dbSNP
rs545612677 82 dbSNP
rs1390349375 87 dbSNP
rs1315751398 92 dbSNP
rs1406943929 95 dbSNP
rs982339611 96 dbSNP
rs1162604119 97 dbSNP
rs923903756 105 dbSNP
rs558911915 106 dbSNP
rs1019295601 114 dbSNP
rs1360769987 116 dbSNP
rs935242097 117 dbSNP
rs1248857589 120 dbSNP
rs1053819788 123 dbSNP
rs1290042917 138 dbSNP
rs752144343 139 dbSNP
rs1261347343 142 dbSNP
rs1205411146 144 dbSNP
rs1224038985 145 dbSNP
rs528120365 147 dbSNP
rs1289537914 150 dbSNP
rs1050475009 151 dbSNP
rs547635108 158 dbSNP
rs1009093778 159 dbSNP
rs1218763065 167 dbSNP
rs1243875918 174 dbSNP
rs957847734 175 dbSNP
rs1036937445 176 dbSNP
rs916468652 183 dbSNP
rs561256120 189 dbSNP
rs949347184 192 dbSNP
rs1322607598 196 dbSNP
rs376335210 199 dbSNP
rs1402441267 207 dbSNP
rs1171257927 222 dbSNP
rs1384317160 232 dbSNP
rs907879986 234 dbSNP
rs1430173047 236 dbSNP
rs1478439434 237 dbSNP
rs1172038285 238 dbSNP
rs1202242863 239 dbSNP
rs1197139347 250 dbSNP
rs1352425964 253 dbSNP
rs530198430 257 dbSNP
rs1302889980 258 dbSNP
rs1037788225 259 dbSNP
rs899273973 260 dbSNP
rs1270193885 262 dbSNP
rs777482144 264 dbSNP
rs1367812454 271 dbSNP
rs995018031 275 dbSNP
rs748749813 276 dbSNP
rs1378826328 277 dbSNP
rs1050597644 286 dbSNP
rs1455036592 288 dbSNP
rs1445878350 297 dbSNP
rs890679021 300 dbSNP
rs577609885 303 dbSNP
rs888091068 306 dbSNP
rs1011964736 309 dbSNP
rs1023412665 315 dbSNP
rs1382403729 316 dbSNP
rs1171975782 318 dbSNP
rs1215552907 319 dbSNP
rs1178573172 326 dbSNP
rs1275317160 327 dbSNP
rs1305962936 331 dbSNP
rs1204138714 333 dbSNP
rs1211675944 342 dbSNP
rs970865090 343 dbSNP
rs867346685 345 dbSNP
rs1277564602 346 dbSNP
rs747512709 350 dbSNP
rs1231613920 362 dbSNP
rs550370108 363 dbSNP
rs1031243623 371 dbSNP
rs1309633077 371 dbSNP
rs956657037 374 dbSNP
rs999170033 375 dbSNP
rs1448901106 379 dbSNP
rs1311303923 386 dbSNP
rs28384119 387 dbSNP
rs1381349916 390 dbSNP
rs915261595 391 dbSNP
rs931938560 396 dbSNP
rs1416637264 399 dbSNP
rs146371062 401 dbSNP
rs1475592288 402 dbSNP
rs1483326684 403 dbSNP
rs552752255 405 dbSNP
rs990587688 416 dbSNP
rs1062930 417 dbSNP
rs115350882 420 dbSNP
rs1251561980 421 dbSNP
rs1036542567 424 dbSNP
rs535026948 425 dbSNP
rs1193539111 426 dbSNP
rs1314879077 428 dbSNP
rs1257742128 431 dbSNP
rs1442923955 433 dbSNP
rs1314849303 445 dbSNP
rs1182928983 446 dbSNP
rs1383084123 448 dbSNP
rs1378536507 452 dbSNP
rs930916026 453 dbSNP
rs1169417426 455 dbSNP
rs1372693998 457 dbSNP
rs1460691435 458 dbSNP
rs907823941 469 dbSNP
rs1297784049 470 dbSNP
rs940685338 476 dbSNP
rs17703870 481 dbSNP
rs796151537 487 dbSNP
rs1423677093 488 dbSNP
rs1452472370 496 dbSNP
rs894717902 501 dbSNP
rs1011892474 502 dbSNP
rs1335320943 506 dbSNP
rs1367745275 507 dbSNP
rs1436305244 508 dbSNP
rs1023719587 509 dbSNP
rs574700748 511 dbSNP
rs1478505131 512 dbSNP
rs932072641 515 dbSNP
rs1306556274 516 dbSNP
rs906316286 521 dbSNP
rs771951064 522 dbSNP
rs1323634012 525 dbSNP
rs1458712350 525 dbSNP
rs1222254841 527 dbSNP
rs1202917312 534 dbSNP
rs1334005377 537 dbSNP
rs1003669269 538 dbSNP
rs1241227111 540 dbSNP
rs761955256 548 dbSNP
rs1188927647 550 dbSNP
rs1030835848 556 dbSNP
rs956500696 557 dbSNP
rs192939514 565 dbSNP
rs1041953100 571 dbSNP
rs1022248393 576 dbSNP
rs184678991 581 dbSNP
rs1392981988 582 dbSNP
rs1173421377 583 dbSNP
rs1284170729 588 dbSNP
rs986185076 589 dbSNP
rs1031985423 590 dbSNP
rs1325708128 591 dbSNP
rs1269225862 592 dbSNP
rs1201878841 593 dbSNP
rs1262644737 597 dbSNP
rs1467840730 599 dbSNP
rs768572442 601 dbSNP
rs1447484370 602 dbSNP
rs1271264890 603 dbSNP
rs577001956 608 dbSNP
rs893515857 632 dbSNP
rs536437976 636 dbSNP
rs1250768756 638 dbSNP
rs545877722 639 dbSNP
rs189168937 640 dbSNP
rs1023842181 641 dbSNP
rs1334019325 643 dbSNP
rs970585407 655 dbSNP
rs1474965590 658 dbSNP
rs1166756232 659 dbSNP
rs1460004246 662 dbSNP
rs572464669 673 dbSNP
rs1003813118 679 dbSNP
rs1453631254 680 dbSNP
rs919447145 685 dbSNP
rs1180441341 687 dbSNP
rs1014832766 693 dbSNP
rs1458130244 693 dbSNP
rs952555780 697 dbSNP
rs776707814 701 dbSNP
rs983981989 701 dbSNP
rs953409031 708 dbSNP
rs986210488 708 dbSNP
rs111589174 712 dbSNP
rs1241533635 712 dbSNP
rs796957047 712 dbSNP
rs73941233 713 dbSNP
rs28497395 716 dbSNP
rs1389242486 717 dbSNP
rs1479141106 718 dbSNP
rs1175055811 719 dbSNP
rs1049200571 722 dbSNP
rs1433639311 725 dbSNP
rs1393077642 726 dbSNP
rs1401790940 729 dbSNP
rs541439320 729 dbSNP
rs1363198696 730 dbSNP
rs944879628 730 dbSNP
rs1179572049 731 dbSNP
rs1425695588 733 dbSNP
rs1320919608 740 dbSNP
rs1256885056 749 dbSNP
rs561217435 752 dbSNP
rs1484785467 753 dbSNP
rs530396509 758 dbSNP
rs1288396618 761 dbSNP
rs1217858973 763 dbSNP
rs1350401088 764 dbSNP
rs139672681 766 dbSNP
rs1247545090 767 dbSNP
rs1303936523 768 dbSNP
rs936258951 768 dbSNP
rs1293329551 771 dbSNP
rs1413817791 775 dbSNP
rs1347600321 777 dbSNP
rs1373291844 777 dbSNP
rs1299622047 789 dbSNP
rs1401142967 789 dbSNP
rs1221960817 792 dbSNP
rs1383957261 792 dbSNP
rs1053349656 799 dbSNP
rs1282723830 799 dbSNP
rs1369149517 804 dbSNP
rs1187372319 805 dbSNP
rs1351574777 807 dbSNP
rs1225340885 808 dbSNP
rs372275104 811 dbSNP
rs948964991 815 dbSNP
rs1044743393 817 dbSNP
rs1194636886 818 dbSNP
rs1044804566 819 dbSNP
rs1222978845 822 dbSNP
rs1357617231 824 dbSNP
rs563904377 824 dbSNP
rs143098365 825 dbSNP
rs1003349876 826 dbSNP
rs1015190041 834 dbSNP
rs1003312032 838 dbSNP
rs1430937767 839 dbSNP
rs1315901160 843 dbSNP
rs961918466 843 dbSNP
rs1406854871 844 dbSNP
rs17173122 846 dbSNP
rs3074117 846 dbSNP
rs397710997 846 dbSNP
rs1425791849 847 dbSNP
rs66740894 847 dbSNP
rs1168714160 850 dbSNP
rs202110719 859 dbSNP
rs552662548 869 dbSNP
rs566197444 880 dbSNP
rs1052584196 881 dbSNP
rs1232941595 888 dbSNP
rs3210694 890 dbSNP
rs181582756 892 dbSNP
rs1212353725 897 dbSNP
rs1332052288 899 dbSNP
rs1010765548 907 dbSNP
rs3210695 910 dbSNP
rs3210696 911 dbSNP
rs1214829960 917 dbSNP
rs1338400972 919 dbSNP
rs376637835 924 dbSNP
rs1406453224 926 dbSNP
rs3210697 928 dbSNP
rs1438425420 929 dbSNP
rs986565425 938 dbSNP
rs3210698 940 dbSNP
rs1022132306 951 dbSNP
rs3210699 952 dbSNP
rs761816943 953 dbSNP
rs1409433875 956 dbSNP
rs1367920187 957 dbSNP
rs1174534249 961 dbSNP
rs3210700 966 dbSNP
rs3210701 967 dbSNP
rs953284740 969 dbSNP
rs1403316247 973 dbSNP
rs1455023495 977 dbSNP
rs1394799780 982 dbSNP
rs1192313172 988 dbSNP
rs1459452622 989 dbSNP
rs548583009 990 dbSNP
rs1336360498 991 dbSNP
rs924789419 999 dbSNP
rs1436716989 1005 dbSNP
rs532538794 1007 dbSNP
rs3210702 1023 dbSNP
rs773723845 1029 dbSNP
rs1348326744 1030 dbSNP
rs1349845071 1033 dbSNP
rs1302358595 1035 dbSNP
rs1232013997 1040 dbSNP
rs966413111 1041 dbSNP
rs1054634152 1042 dbSNP
rs1379091539 1055 dbSNP
rs568398535 1067 dbSNP
rs919366655 1068 dbSNP
rs1441655239 1076 dbSNP
rs1352828168 1080 dbSNP
rs916189092 1082 dbSNP
rs1435500187 1085 dbSNP
rs1375253079 1087 dbSNP
rs2011339 1092 dbSNP
rs1357087149 1093 dbSNP
rs1177122067 1097 dbSNP
rs984957940 1105 dbSNP
rs916045023 1106 dbSNP
rs1250835328 1111 dbSNP
rs773529836 1119 dbSNP
rs1179017354 1122 dbSNP
rs1046380607 1125 dbSNP
rs1485765117 1126 dbSNP
rs557018985 1129 dbSNP
rs1439615214 1130 dbSNP
rs1355581738 1131 dbSNP
rs1184810150 1132 dbSNP
rs927663440 1139 dbSNP
rs939042605 1147 dbSNP
rs372446646 1148 dbSNP
rs906258651 1149 dbSNP
rs1415652241 1165 dbSNP
rs1375110374 1170 dbSNP
rs763050674 1171 dbSNP
rs1387402645 1173 dbSNP
rs1311283823 1185 dbSNP
rs1052086923 1187 dbSNP
rs562771369 1195 dbSNP
rs1397513679 1197 dbSNP
rs1036165424 1204 dbSNP
rs1010628057 1208 dbSNP
rs34742306 1214 dbSNP
rs1405189838 1217 dbSNP
rs1043584331 1233 dbSNP
rs994695154 1234 dbSNP
rs888929842 1242 dbSNP
rs1007489778 1246 dbSNP
rs1261027331 1252 dbSNP
rs889049500 1254 dbSNP
rs1007535422 1256 dbSNP
rs866492687 1263 dbSNP
rs1291911432 1267 dbSNP
rs1234048091 1273 dbSNP
rs539255335 1279 dbSNP
rs1317094841 1282 dbSNP
rs62130745 1284 dbSNP
rs572624256 1292 dbSNP
rs977899679 1298 dbSNP
rs1363124612 1301 dbSNP
rs993945959 1317 dbSNP
rs1429030451 1319 dbSNP
rs1026265521 1320 dbSNP
rs1166284034 1326 dbSNP
rs1193782524 1328 dbSNP
rs952138213 1329 dbSNP
rs374774373 1336 dbSNP
rs1416456439 1337 dbSNP
rs1271662137 1346 dbSNP
rs984800381 1348 dbSNP
rs916136751 1355 dbSNP
rs916097381 1359 dbSNP
rs970600723 1361 dbSNP
rs1254874219 1380 dbSNP
rs559352805 1381 dbSNP
rs1461385868 1385 dbSNP
rs981618873 1387 dbSNP
rs1271304255 1389 dbSNP
rs928902765 1393 dbSNP
rs1295082907 1394 dbSNP
rs541552130 1395 dbSNP
rs1370168694 1398 dbSNP
rs1440732879 1403 dbSNP
rs1393137789 1408 dbSNP
rs1052110864 1411 dbSNP
rs555326015 1413 dbSNP
rs1463052748 1414 dbSNP
rs1187259383 1420 dbSNP
rs927628502 1422 dbSNP
rs1426530546 1429 dbSNP
rs913533212 1434 dbSNP
rs1194219341 1435 dbSNP
rs1166432194 1440 dbSNP
rs946469337 1443 dbSNP
rs1197668206 1451 dbSNP
rs1043468744 1452 dbSNP
rs888855982 1458 dbSNP
rs943221280 1467 dbSNP
rs939065955 1469 dbSNP
rs1225448178 1478 dbSNP
rs148784303 1485 dbSNP
rs1234232293 1487 dbSNP
rs1304580439 1487 dbSNP
rs897605489 1489 dbSNP
rs544048055 1491 dbSNP
rs993393975 1495 dbSNP
rs1026275469 1498 dbSNP
rs563836469 1504 dbSNP
rs1396516675 1507 dbSNP
rs1395422945 1512 dbSNP
rs1006274462 1515 dbSNP
rs1328038742 1520 dbSNP
rs888993641 1521 dbSNP
rs142515518 1527 dbSNP
rs768067922 1528 dbSNP
rs754152322 1532 dbSNP
rs1277181427 1536 dbSNP
rs150922166 1538 dbSNP
rs1453538107 1539 dbSNP
rs1393262146 1546 dbSNP
rs1183890437 1550 dbSNP
rs1419763386 1560 dbSNP
rs532705434 1568 dbSNP
rs1381425514 1579 dbSNP
rs1323565153 1581 dbSNP
rs970148292 1591 dbSNP
rs759231313 1598 dbSNP
rs1205045218 1599 dbSNP
rs982054441 1602 dbSNP
rs1035852416 1603 dbSNP
rs1460350199 1604 dbSNP
rs956494452 1611 dbSNP
rs989040745 1613 dbSNP
rs753428655 1614 dbSNP
rs913585264 1628 dbSNP
rs1240303341 1629 dbSNP
rs1007894412 1632 dbSNP
rs796176488 1636 dbSNP
rs14185 1638 dbSNP
rs1449112195 1639 dbSNP
rs979075922 1641 dbSNP
rs910333281 1643 dbSNP
rs1018896007 1644 dbSNP
rs901836506 1650 dbSNP
rs1313104050 1658 dbSNP
rs943125849 1660 dbSNP
rs1040617703 1663 dbSNP
rs901636658 1665 dbSNP
rs546443920 1669 dbSNP
rs1373332367 1670 dbSNP
rs1160233756 1671 dbSNP
rs560019988 1674 dbSNP
rs1031706071 1680 dbSNP
rs1363326902 1703 dbSNP
Experimental Support 1 for Functional miRNA-Target Interaction
miRNA:Target ----
Validation Method
     
Conditions A549
Location of target site 3'UTR
Tools used in this research MicroCosm , TargetScan
Original Description (Extracted from the article) ... "Interestingly ...

- Bertero T; Grosso S; Robbe-Sermesant K; et al., 2012, PloS one.

Article - Bertero T; Grosso S; Robbe-Sermesant K; et al.
- PloS one, 2012
Specificity of interaction between a microRNA (miRNA) and its targets crucially depends on the seed region located in its 5'-end. It is often implicitly considered that two miRNAs sharing the same biological activity should display similarity beyond the strict six nucleotide region that forms the seed, in order to form specific complexes with the same mRNA targets. We have found that expression of hsa-miR-147b and hsa-miR-210, though triggered by different stimuli (i.e. lipopolysaccharides and hypoxia, respectively), induce very similar cellular effects in term of proliferation, migration and apoptosis. Hsa-miR-147b only shares a "minimal" 6-nucleotides seed sequence with hsa-miR-210, but is identical with hsa-miR-147a over 20 nucleotides, except for one base located in the seed region. Phenotypic changes induced after heterologous expression of miR-147a strikingly differ from those induced by miR-147b or miR-210. In particular, miR-147a behaves as a potent inhibitor of cell proliferation and migration. These data fit well with the gene expression profiles observed for miR-147b and miR-210, which are very similar, and the gene expression profile of miR-147a, which is distinct from the two others. Bioinformatics analysis of all human miRNA sequences indicates multiple cases of miRNAs from distinct families exhibiting the same kind of similarity that would need to be further characterized in terms of putative functional redundancy. Besides, it implies that functional impact of some miRNAs can be masked by robust expression of miRNAs belonging to distinct families.
LinkOut: [PMID: 23028679]
MiRNA-Target Expression Profile
Dataset Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
MiRNA-Target Expression Profile (TCGA)
Tumor Pearson Correlation P-value for Pearson Correlation Spearman Correlation P-value for Spearman Correlation Samples Chart
LIHC -0.398 0 -0.328 0.01 49 Click to see details
STAD -0.419 0.01 -0.372 0.02 32 Click to see details
HNSC -0.322 0.02 -0.392 0.01 42 Click to see details
ESCA -0.594 0.03 -0.636 0.02 11 Click to see details
BRCA -0.19 0.04 -0.144 0.1 84 Click to see details
BLCA -0.38 0.06 -0.399 0.05 18 Click to see details
UCEC -0.34 0.08 -0.396 0.05 19 Click to see details
CHOL -0.49 0.09 -0.400 0.14 9 Click to see details
LUSC -0.17 0.15 -0.234 0.08 38 Click to see details
PCPG -0.863 0.17 -0.500 0.33 3 Click to see details
PAAD 0.574 0.21 0.400 0.3 4 Click to see details
KIRP -0.141 0.22 -0.125 0.25 32 Click to see details
COAD -0.318 0.22 -0.286 0.25 8 Click to see details
THCA 0.075 0.29 0.060 0.33 59 Click to see details
KIRC 0.066 0.3 0.163 0.09 68 Click to see details
KICH -0.097 0.32 -0.158 0.23 25 Click to see details
LUAD -0.142 0.33 -0.168 0.3 12 Click to see details
PRAD 0.053 0.36 -0.022 0.44 50 Click to see details
CESC -0.337 0.39 -0.500 0.33 3 Click to see details
CESC -0.337 0.39 -0.500 0.33 3 Click to see details
CESC -0.337 0.39 -0.500 0.33 3 Click to see details
126 hsa-miR-210-3p Target Genes:
Functional analysis:
ID Target Description Validation methods
Strong evidence Less strong evidence
MIRT000149 HOXA9 homeobox A9 4 1
MIRT000150 TP53I11 tumor protein p53 inducible protein 11 2 1
MIRT000151 PIM1 Pim-1 proto-oncogene, serine/threonine kinase 2 1
MIRT000152 HOXA1 homeobox A1 2 1
MIRT000153 FGFRL1 fibroblast growth factor receptor like 1 6 3
MIRT000156 RAD52 RAD52 homolog, DNA repair protein 5 3
MIRT001930 NPTX1 neuronal pentraxin 1 3 2
MIRT002024 EFNA3 ephrin A3 8 8
MIRT003153 BDNF brain derived neurotrophic factor 5 1
MIRT003154 PTPN1 protein tyrosine phosphatase, non-receptor type 1 5 1
MIRT003155 P4HB prolyl 4-hydroxylase subunit beta 6 2
MIRT003156 UBQLN1 ubiquilin 1 3 1
MIRT003157 SERTAD2 SERTA domain containing 2 3 1
MIRT003158 SEH1L SEH1 like nucleoporin 3 1
MIRT003159 NCAM1 neural cell adhesion molecule 1 4 1
MIRT003160 MID1IP1 MID1 interacting protein 1 3 1
MIRT003161 MDGA1 MAM domain containing glycosylphosphatidylinositol anchor 1 3 1
MIRT003162 KIAA1161 myogenesis regulating glycosidase (putative) 3 1
MIRT003163 ISCU iron-sulfur cluster assembly enzyme 6 7
MIRT003164 HOXA3 homeobox A3 3 1
MIRT003165 GPD1L glycerol-3-phosphate dehydrogenase 1 like 7 2
MIRT003166 DENND6A DENN domain containing 6A 3 1
MIRT003167 CPEB2 cytoplasmic polyadenylation element binding protein 2 5 1
MIRT003168 CDK10 cyclin dependent kinase 10 3 1
MIRT003169 ABCB9 ATP binding cassette subfamily B member 9 3 1
MIRT003170 CBX1 chromobox 1 3 1
MIRT003171 XIST X inactive specific transcript (non-protein coding) 4 1
MIRT003172 TNPO1 transportin 1 3 1
MIRT003173 SMCHD1 structural maintenance of chromosomes flexible hinge domain containing 1 3 1
MIRT003174 PTAR1 protein prenyltransferase alpha subunit repeat containing 1 3 1
MIRT003175 NIPBL NIPBL, cohesin loading factor 3 1
MIRT003176 MIB1 mindbomb E3 ubiquitin protein ligase 1 3 1
MIRT003177 HECTD1 HECT domain E3 ubiquitin protein ligase 1 3 1
MIRT003178 ELK3 ELK3, ETS transcription factor 3 1
MIRT003179 DDAH1 dimethylarginine dimethylaminohydrolase 1 4 1
MIRT003180 CLASP2 cytoplasmic linker associated protein 2 3 1
MIRT003181 CHD9 chromodomain helicase DNA binding protein 9 3 1
MIRT003182 ATP11C ATPase phospholipid transporting 11C 3 1
MIRT003183 APC APC, WNT signaling pathway regulator 3 1
MIRT003184 E2F3 E2F transcription factor 3 7 5
MIRT003185 ACVR1B activin A receptor type 1B 2 1
MIRT003916 MRE11A MRE11 homolog, double strand break repair nuclease 2 1
MIRT003917 XPA XPA, DNA damage recognition and repair factor 2 1
MIRT004672 MNT MAX network transcriptional repressor 4 2
MIRT006326 AIFM3 apoptosis inducing factor, mitochondria associated 3 3 2
MIRT006519 CASP8AP2 caspase 8 associated protein 2 4 1
MIRT006663 VMP1 vacuole membrane protein 1 3 2
MIRT006830 TFRC transferrin receptor 3 2
MIRT047002 PFDN2 prefoldin subunit 2 1 1
MIRT047003 U2AF2 U2 small nuclear RNA auxiliary factor 2 1 1
MIRT047004 UBA1 ubiquitin like modifier activating enzyme 1 1 1
MIRT047005 ESPL1 extra spindle pole bodies like 1, separase 1 1
MIRT047006 ACTR1A ARP1 actin related protein 1 homolog A 1 1
MIRT047007 SCN1B sodium voltage-gated channel beta subunit 1 1 1
MIRT047008 RCC2 regulator of chromosome condensation 2 1 1
MIRT053179 HSD17B1 hydroxysteroid 17-beta dehydrogenase 1 2 1
MIRT054098 NDUFA4 NDUFA4, mitochondrial complex associated 4 2
MIRT054099 SDHD succinate dehydrogenase complex subunit D 6 4
MIRT054141 STMN1 stathmin 1 3 1
MIRT054142 DIMT1L DIM1 dimethyladenosine transferase 1 homolog 4 2
MIRT054186 ROD1 polypyrimidine tract binding protein 3 3 1
MIRT054203 ALDH5A1 aldehyde dehydrogenase 5 family member A1 4 1
MIRT054204 FOXN3 forkhead box N3 5 2
MIRT054205 MCM3 minichromosome maintenance complex component 3 4 1
MIRT054206 IGFBP3 insulin like growth factor binding protein 3 6 2
MIRT054207 COL4A2 collagen type IV alpha 2 chain 6 2
MIRT054208 INPP5A inositol polyphosphate-5-phosphatase A 4 1
MIRT054209 EHD2 EH domain containing 2 4 1
MIRT054210 SH3BGRL SH3 domain binding glutamate rich protein like 5 2
MIRT054248 PTPN2 protein tyrosine phosphatase, non-receptor type 2 3 1
MIRT054321 LDHA lactate dehydrogenase A 2 1
MIRT054324 LDHB lactate dehydrogenase B 2 1
MIRT054349 HIF1A hypoxia inducible factor 1 alpha subunit 5 2
MIRT054714 FOXP3 forkhead box P3 3 1
MIRT054794 HIF3A hypoxia inducible factor 3 alpha subunit 3 1
MIRT115688 MGRN1 mahogunin ring finger 1 2 3
MIRT170674 INSIG1 insulin induced gene 1 1 1
MIRT437785 BNIP3 BCL2 interacting protein 3 5 2
MIRT438739 KCMF1 potassium channel modulatory factor 1 1 1
MIRT439407 TNPO3 transportin 3 1 1
MIRT439629 SIPA1L3 signal induced proliferation associated 1 like 3 1 1
MIRT439632 SIN3A SIN3 transcription regulator family member A 1 1
MIRT439740 RPL22 ribosomal protein L22 1 1
MIRT439886 PSAP prosaposin 1 1
MIRT439918 PPP1R2 protein phosphatase 1 regulatory inhibitor subunit 2 1 1
MIRT439928 POU2AF1 POU class 2 associating factor 1 1 1
MIRT440033 ICMT isoprenylcysteine carboxyl methyltransferase 2 3
MIRT440255 MEF2D myocyte enhancer factor 2D 1 1
MIRT440491 HMGCS1 3-hydroxy-3-methylglutaryl-CoA synthase 1 2 3
MIRT440570 GIT2 GIT ArfGAP 2 1 1
MIRT440647 FCHSD2 FCH and double SH3 domains 2 1 1
MIRT440830 DEAF1 DEAF1, transcription factor 1 1
MIRT440866 CSNK1E casein kinase 1 epsilon 1 1
MIRT472232 NFIC nuclear factor I C 2 2
MIRT473190 MITF melanogenesis associated transcription factor 2 2
MIRT477856 DYRK2 dual specificity tyrosine phosphorylation regulated kinase 2 2 2
MIRT497528 ZNF607 zinc finger protein 607 2 2
MIRT509770 SERTM1 serine rich and transmembrane domain containing 1 2 6
MIRT524407 CNTNAP5 contactin associated protein like 5 2 4
MIRT535209 PKIA cAMP-dependent protein kinase inhibitor alpha 2 4
MIRT554511 RUNX1T1 RUNX1 translocation partner 1 2 4
MIRT558069 ESCO2 establishment of sister chromatid cohesion N-acetyltransferase 2 2 2
MIRT572273 KCNJ6 potassium voltage-gated channel subfamily J member 6 2 2
MIRT574255 DOCK7 dedicator of cytokinesis 7 2 4
MIRT575621 Foxn3 forkhead box N3 2 2
MIRT575742 Zfp618 zinc finger protein 618 1 1
MIRT609050 VAMP4 vesicle associated membrane protein 4 2 2
MIRT611143 TNRC6B trinucleotide repeat containing 6B 2 4
MIRT699226 SLCO3A1 solute carrier organic anion transporter family member 3A1 2 2
MIRT703060 GTDC1 glycosyltransferase like domain containing 1 2 2
MIRT716005 ASB11 ankyrin repeat and SOCS box containing 11 2 2
MIRT731682 BTK Bruton tyrosine kinase 3 1
MIRT733090 DLEU2L deleted in lymphocytic leukemia 2-like 3 0
MIRT733091 BRCA2 BRCA2, DNA repair associated 3 0
MIRT733156 ITGA5 integrin subunit alpha 5 1 0
MIRT733501 GATA1 GATA binding protein 1 3 0
MIRT733503 SMAD2 SMAD family member 2 3 0
MIRT733525 MIR210HG MIR210 host gene 2 0
MIRT733615 TGFBI transforming growth factor beta induced 2 0
MIRT734175 KRAS KRAS proto-oncogene, GTPase 2 0
MIRT734293 PTEN phosphatase and tensin homolog 1 0
MIRT734568 STAT6 signal transducer and activator of transcription 6 1 0
MIRT734966 ADAMTS6 ADAM metallopeptidase with thrombospondin type 1 motif 6 1 0
MIRT736294 ID2 inhibitor of DNA binding 2, HLH protein 1 0
MIRT737104 FABP4 fatty acid binding protein 4, adipocyte 3 0
MIRT756028 NTN4 netrin 4 3 1
miRNA-Drug Associations
miRNA Small Melocule FDA CID Detection Method Condition PMID Year Expression Pattern of miRNA
miR-210 Vincristine approved 5978 Quantitative real-time PCR Hep-2 cells 23780424 2013 up-regualted
miR-210 Lenalidomide approved 216326 Quantitative real-time PCR peripheral blood CD14+ monocytes 25287904 2014 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray lymphoblast cell line TK-6 17108120 2006 down-regulated
miR-210 5-Fluorouracil approved 3385 Quantitative real-time PCR colon cancer cells 17702597 2007 down-regulated
miR-210 Arsenic trioxide approved 14888 Microarray HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Arsenic trioxide approved 14888 Quantitative real-time PCR HepG-2 human hepatocellular carcinoma cell line 21175813 2011 up-regulated
miR-210 Ginsenoside Rh2 NULL 119307 Microarray human glioma cells U251 21372826 2011 down-regulated
miR-210 Aidi injection NULL NULL Microarray human breast cancer cells 21563499 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer HB2 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer MDA-MB231 22076154 2011 down-regulated
miR-210 5-aza-2'-deoxycytidine (5-Aza-CdR) approved 451668 Microarray breast cancer SKBR3 22076154 2011 down-regulated
miR-210 Trastuzumab approved NULL Microarray HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Quantitative real-time PCR HER2-positive breast cancer 22384020 2012 down-regulated
miR-210 Trastuzumab approved NULL Microarray BT474 cells 22384020 2012 down-regulated
miR-210 Curcumin NULL 969516 Quantitative real-time PCR Y79 RB cells. 22510010 2012 down-regulated
miR-210 Bicalutamide approved 2375 Microarray prostate 22674191 2012 down-regulated
miR-210 Goserelin approved 47725 Microarray prostate 22674191 2012 down-regulated
miR-210 Olea europaea leaf extract NULL NULL Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Temozolomide approved 5394 Quantitative real-time PCR glioblastoma cells. 22722712 2012 up-regulated
miR-210 Nicotine approved 89594 Microarray Rat adrenal pheochromocytoma PC12 cell 18845019 2009 down-regulated
miR-210 Comfrey NULL 6440495 Microarray rat liver 21370286 2011 up-regulated
miRNA-Drug Resistance Associations
miRNA Drug Name CID NSC FDA Effect/Pattern Detection Method Level Phenotype Condition
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant High Gastric Cancer cell line (BGC823)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-mir-210 Dabrafenib 44462760 NSC764134 approved resistant cell line (A375)
hsa-mir-210 Paclitaxel 36314 NSC125973 approved resistant cell line (W1)
hsa-mir-210 Androstenedione 6128 NSC9563 sensitive cell line (MCF-7)
hsa-mir-210 Androstenedione+Letrozole sensitive cell line (MCF-7)
hsa-mir-210 Tamoxifen 2733525 NSC180973 approved resistant tissue (ER-positive breast cancer)
hsa-mir-210 Fluorouracil 3385 NSC19893 approved sensitive cell line (OE19)
hsa-mir-210 Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-mir-210 Cisplatin 5460033 NSC119875 approved resistant cell line (BGC-823)
hsa-miR-210-3p (E)-1-[3,5-bis[(dimethylamino)methyl]-4-hydroxyphenyl]-3-phenylprop-2-en-1-one 6374691 NSC677784 resistant
hsa-miR-210-3p (e)-3-chloro-3-(4-methoxyphenyl)-2-(4-nitrophenyl)prop-2-enal 5387396 NSC623175 resistant
hsa-miR-210-3p [(E)-(1-chloro-2-methylpropylidene)amino] N-anilinocarbamate 5494354 NSC682841 resistant
hsa-miR-210-3p [(E)-1-chloropropylideneamino] N-[2-(trifluoromethoxy)phenyl]carbamate 5466266 NSC682836 resistant
hsa-miR-210-3p [2-[(e)-(carbamothioylhydrazono)methyl]-6-methoxy-phenoxy]-hydroxy-copper; 2-(2-pyridyl)pyridine 135484845 NSC638302 resistant
hsa-miR-210-3p 1-(4-ethoxyphenyl)-3-(2-methyl-5-propan-2-ylphenyl)urea 240168 NSC46213 sensitive
hsa-miR-210-3p 1-(4-nitrophenyl)-3-(2-pyridyl)thiourea 3005383 NSC695329 sensitive
hsa-miR-210-3p 1-(naphthalen-1-ylmethyl)-4-[1-(naphthalen-1-ylmethyl)piperidin-4-yl]piperidine 364095 NSC669995 resistant
hsa-miR-210-3p 1-[2-(4-nitrophenyl)-2-oxoethyl]-4-pentylpyridin-1-ium bromide 24181037 NSC4290 resistant
hsa-miR-210-3p 11-(3-methoxyphenyl)-2,12,15-triazapentacyclo[11.7.1.03,8.09,21.014,19]henicosa-1,3,5,7,9,11,13(21),14(19),15,17-decaen-20-one 54608964 NSC697747 resistant
hsa-miR-210-3p 17-acetyl-9,14-dihydroxy-16-methyl-15-(4-methylphenyl)-15-azatetracyclo[8.7.0.01,14.03,8]heptadeca-3,5,7,9,12,16-hexaene-2,11-dione 405612 NSC722982 resistant
hsa-miR-210-3p 1h-benz[g]indol-5-ol, 2-phenyl 371327 NSC645431 resistant
hsa-miR-210-3p 2-[[4-anilino-5-[8-[4-anilino-5-[(1-hydroxynaphthalen-2-yl)oxymethyl]-1,2,4-triazol-3-yl]octyl]-1,2,4-triazol-3-yl]methoxy]naphthalen-1-ol 394049 NSC697167 resistant
hsa-miR-210-3p 2-[9-[(7-oxocyclohepta-1,3,5-trien-1-yl)amino]nonylamino]cyclohepta-2,4,6-trien-1-one 358331 NSC618296 resistant
hsa-miR-210-3p 2-amino-5,8-dihydroxy-1,4-naphthoquinone 377209 NSC658441 resistant
hsa-miR-210-3p 2-bromo-4-(5-fluoro-1,3-benzothiazol-2-yl)aniline 399248 NSC709925 sensitive
hsa-miR-210-3p 2-hydroxy-5-({(e)-[(10-hydroxyacridin-9(10h)-ylidene)methyl]diazenyl}sulfonyl)benzoic acid 363212 NSC627890 resistant
hsa-miR-210-3p 3'-chloro-3-nitro-o-salicylotoluidide 332278 NSC328477 resistant
hsa-miR-210-3p 3-((4-(methylthio)phenoxy)methyl)-2-oxiranol 366923 NSC636087 resistant
hsa-miR-210-3p 4-(2-phenylethylamino)naphthalene-1,2-dione 367789 NSC637731 resistant
hsa-miR-210-3p 4-[(E)-2-piperidin-1-ylethenyl]benzo[g]quinoline-5,10-dione 5781544 NSC642968 resistant
hsa-miR-210-3p 4-[(r)-[(2s,5r)-2,5-dimethyl-4-prop-2-enylpiperazin-1-yl]-(3-methoxyphenyl)methyl]-n-pentan-3-ylbenzamide;hydrochloride 5471112 NSC708822 resistant
hsa-miR-210-3p 4-[2-(methylamino)-1-methylsulfanylethyl]benzene-1,2-diol 412349 NSC39215 resistant
hsa-miR-210-3p 4-[4-(4-sulfinobutyldisulfanyl)butyldisulfanyl]butane-1-sulfinic acid 361262 NSC624205 resistant
hsa-miR-210-3p 4-acetamido-n-[(e)-(2,4-dichlorophenyl)methylideneamino]-2-methoxybenzamide 9572428 NSC716142 sensitive
hsa-miR-210-3p 4-aminodithiolane-4-carboxylic acid 269217 NSC109825 resistant
hsa-miR-210-3p 4-hydroxy-3-[1-(1-hydroxy-3,4-dioxonaphthalen-2-yl)-3-phenylpropyl]naphthalene-1,2-dione 272651 NSC117274 resistant
hsa-miR-210-3p 4,4-dimethylspiro[1,3,2-oxazaphospholidin-2-ium-2,2'-3h-1,3,2-benzoxazaphosphol-2-ium]-5-one 6330525 NSC351866 resistant
hsa-miR-210-3p 4b-hydroxy-10,10-dimethoxy-9ah-indeno[1,2-a]inden-9-one 363252 NSC628000 resistant
hsa-miR-210-3p 4h,7h-furo[2',3',4':4,5]naphth[2,1-e][1,3]oxazin-4-one, 8-(4-chlorophenyl)-8,9-dihydro- 373969 NSC651001 resistant
hsa-miR-210-3p 5,6,7-trimethoxy-N-(4H-pyrazolo[1,5-a]indol-2-yl)-1H-indole-2-carboxamide 404173 NSC720326 resistant
hsa-miR-210-3p 6-(3-chloropropyl)-3-nitroindeno[1,2-c]isoquinoline-5,11-dione 17755848 NSC731154 resistant
hsa-miR-210-3p 6-benzyloxyhexanal 389877 NSC686505 resistant
hsa-miR-210-3p 7-[(E)-2-(1,6-dimethylquinolin-1-ium-2-yl)ethenyl]-5-methylquinolin-8-ol 135483953 NSC86371 resistant
hsa-miR-210-3p 7-[(naphthalen-1-ylamino)(phenyl)methyl]quinolin-8-ol 256754 NSC84092 resistant
hsa-miR-210-3p 7-chloro-6-n-(2-fluoroethylamino)-5,8-quinolinedione 379079 NSC663286 resistant
hsa-miR-210-3p 7-o,8-o-isopropylidene iriomoteolide 3a 24808220 NSC753164 resistant
hsa-miR-210-3p 9h-quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-phenyl- 4567749 NSC686553 resistant
hsa-miR-210-3p Acetyltrophanthidin 261075 NSC92954 resistant
hsa-miR-210-3p Adenosine, 2-bromo-2'-deoxy- 334838 NSC341936 resistant
hsa-miR-210-3p Asimicinone 393461 NSC695394 resistant
hsa-miR-210-3p Benzo[b]naphtho[2,3-d]furan-6,11-dione, 4-chloro-3-hydroxy 371025 NSC644902 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(2,4-dimethylphenyl)-3-methyl- 363228 NSC627974 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 10-(4-chlorophenyl)-3,7,8-trimethyl- 363246 NSC627992 resistant
hsa-miR-210-3p Benzo[g]pteridine-2,4(3h,10h)-dione, 3-methyl-10-[3-(methylthio)phenyl]- 363242 NSC627988 resistant
hsa-miR-210-3p Benzo[g]quinoxaline-5,10-dione, 5,10-dihydro-2,3-dimethyl- 353644 NSC602617 resistant
hsa-miR-210-3p Celcot rm 67277 NSC37168 resistant
hsa-miR-210-3p Cytarabine 6253 NSC287459 approved resistant
hsa-miR-210-3p Destruxin a 122810 NSC361126 resistant
hsa-miR-210-3p Di-p-tolyliodinium bromide 54601177 NSC8985 resistant
hsa-miR-210-3p Diethoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368297 NSC638842 resistant
hsa-miR-210-3p Dihydrorotenone 243725 NSC53866 resistant
hsa-miR-210-3p Diisopropoxybis(1,4-naphthochinone-2-olato)titanium(iv) 368058 NSC638383 resistant
hsa-miR-210-3p Discorhabdin i 135409047 NSC656206 resistant
hsa-miR-210-3p Dpbq 364074 NSC629713 resistant
hsa-miR-210-3p Ethyl 6-chloro-4-phenyl-2-(piperazin-1-ylmethyl)quinoline-3-carboxylate 369623 NSC641536 resistant
hsa-miR-210-3p Ethyl 6-hydroxy-4-(4-methoxyphenyl)-6-methyl-3-oxo-2-phenyl-1,4,5,7-tetrahydroindazole-5-carboxylate 392845 NSC693857 resistant
hsa-miR-210-3p Gnmlngdfmleynr-uhfffaoysa-n 402862 NSC717147 sensitive
hsa-miR-210-3p Gw612286x 9822610 NSC756278 sensitive
hsa-miR-210-3p Gw811761x 6539382 NSC756375 sensitive
hsa-miR-210-3p Herbimycin 6436247 NSC305978 resistant
hsa-miR-210-3p Hypothemycin 5458809 NSC354462 resistant
hsa-miR-210-3p Indole-2,3-dione, 5-methyl-, 3-[(o-nitrophenyl)hydrazone] 3632950 NSC117915 sensitive
hsa-miR-210-3p J3.572.907k 396709 NSC703318 resistant
hsa-miR-210-3p Methyl 10-acetyl-3-(4-methylphenyl)sulfonyl-9-(2-methylprop-1-enyl)-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13),11-pentaene-11-carboxylate NSC621968 resistant
hsa-miR-210-3p Methyl 8-[(4-chlorophenyl)carbamoyl]naphthalene-1-carboxylate 364289 NSC630307 resistant
hsa-miR-210-3p N-(2-morpholin-4-ylethyl)-5-nitroquinolin-4-amine;hydrochloride 372042 NSC646859 resistant
hsa-miR-210-3p N-(3-chloro-1,4-dioxonaphthalen-2-yl)-4-naphthalen-2-yl-2,4-dioxo-3-(3-oxo-1H-2-benzofuran-1-yl)butanamide 369463 NSC641233 resistant
hsa-miR-210-3p N-(3,5-dicyano-2-(4-methylphenyl)-6-oxo-4-phenyl-1(6h)-pyridinyl)-4-methylbenzenesulfonamide 390286 NSC687578 resistant
hsa-miR-210-3p N-[(1E)-1-(1-hydroxypyridin-2-ylidene)ethyl]iminoazepane-1-carbothioamide 5369124 NSC351075 resistant
hsa-miR-210-3p N-[1,1,1,3,3,3-hexafluoro-2-(4-fluoroanilino)propan-2-yl]butanamide 389152 NSC684836 resistant
hsa-miR-210-3p Naphtho[2,3-d]-1,3-dioxepin-6,11-dione, 4-methyl- NSC626868 resistant
hsa-miR-210-3p Naphtho[2,3-d]oxazole-4,9-dione, 2-(1,1-dimethylethyl)- 370622 NSC643915 resistant
hsa-miR-210-3p Niosh/br9826000 359483 NSC620462 resistant
hsa-miR-210-3p NSC619321 NSC619321 sensitive
hsa-miR-210-3p NSC621321 NSC621321 resistant
hsa-miR-210-3p NSC631451 NSC631451 resistant
hsa-miR-210-3p NSC634766 NSC634766 resistant
hsa-miR-210-3p NSC635414 NSC635414 resistant
hsa-miR-210-3p Pentyl 6-(chloromethyl)-2-oxo-2h-chromene-3-carboxylate 402498 NSC716524 resistant
hsa-miR-210-3p Pmp (van) 72508 NSC1906 resistant
hsa-miR-210-3p Scillirosidin, glycoside 222160 NSC7534 resistant
hsa-miR-210-3p Sesbanimide 163490 NSC355461 resistant
hsa-miR-210-3p Snc 80 123924 NSC707484 resistant
hsa-miR-210-3p Streptovaricin b 135443622 NSC156215 resistant
hsa-miR-210-3p Tetratert-butyl 8,11-dimethoxytricyclo[4.3.3.01,6]dodeca-7,10-diene-7,9,10,12-tetracarboxylate 362411 NSC626176 resistant
hsa-miR-210-3p Tolonium chloride 7083 NSC36758 resistant
hsa-miR-210-3p Z48861686 4784054 NSC745813 resistant
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant High Glioblastoma cell line (U251MG, U251R, U87MG, M059K, M059J)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved resistant High Myelogenous Leukemia cell line (MYL)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colon Cancer cell line (HT-29)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Ehrlich Ascites Tumor cell line (EHR2,P6, P12, P36, P72, EHR2/1.3)
hsa-miR-210-3p Trastuzumab resistant Low Breast Cancer tissue and cell line (BT-474, BTR65)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Vincristine 5978 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Gastric Cancer cell line (SGC7901)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant Low Cervical Cancer tissue and cell line (SiHa, Cask)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Laryngeal Cancer cell line (Hep2)
hsa-miR-210-3p Fluorouracil + Oxaliplatin resistant High Colorectal Cancer tissue
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Prostate Cancer cell line (DU-145)
hsa-miR-210-3p Asparaginate 5460875 sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive Low Pediatric Acute Lymphoblastic Leukemia Reh cells
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant High Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive High Esophageal Adenocarcinoma cell line (OE19)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant High Hepatocellular Carcinoma tissue and cell line (HepG2)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant High Pancreatic Cancer cell line (SW1990)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR20)
hsa-miR-210-3p Taxane 9548828 sensitive High Prostate Cancer cell line (PC-3, PR70)
hsa-miR-210-3p Dexamethasone 5743 NSC34521 approved sensitive High Myeloma cell line (MM1R, MM1S)
hsa-miR-210-3p Platinum 23939 sensitive High Ovarian Cancer tissue
hsa-miR-210-3p Daunorubicin 30323 NSC82151 approved sensitive High Acute Myeloid Leukemia cell line (U-937, KG-1)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Ductal Adenocarcinoma cell line (MIA-PaCa-2)
hsa-miR-210-3p Trametinib 11707110 NSC758246 approved sensitive Low Melanoma cell line (MML-1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant Low Breast Cancer cell line (TAMR4, TAMR8)
hsa-miR-210-3p Aromatase Inhibitor sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Epirubicin 41867 NSC256942 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p Vinorelbine 44424639 approved resistant High Breast Cancer cell line (MDA-MB-231)
hsa-miR-210-3p 1'-Acetoxychavicol acetate 119104 NSC711510 resistant Low Cervical Cancer cell line (Ca Ski, SiHa)
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive High Melanoma cell line (A375, IGR37, 501Mel)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Non-Small Cell Lung Cancer cell line (A549)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive High Chronic Myelogenous Leukemia cell line (K562)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Vinblastine 442111 NSC90636 approved sensitive Low Renal Cell Cancer cell line (Caki-2)
hsa-miR-210-3p Fulvestrant 17756771 NSC719276 approved resistant High Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant High Non-Small Cell Lung Cancer cell line (H3122, H2228)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Cancer cell line (LS174T)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Cholangiocarcinoma cell line (KKU-213, KKU-055, KKU-100)
hsa-miR-210-3p Docetaxel 148124 NSC628503 approved resistant Low Breast Cancer tissue
hsa-miR-210-3p Palbociclib 5330286 NSC758247 approved sensitive High Breast Cancer cell line (T47D)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Ovarian Cancer cell line (SKOV3)
hsa-miR-210-3p Cetuximab + Folfox(Fluorouracil + Leucovorin + Oxaliplatin) sensitive High Metastatic Colorectal Cancer tissue
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved sensitive Low Colorectal Cancer cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (BXPC-3)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant High Colorectal Adenocarcinoma cell line (HT-29)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved resistant Low Pancreatic Cancer cell line (PANC-1)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant Low Oral Cancer cell line (SAS, HSC-3, HSC-4)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive High Endometrial Serous Carcinoma cell line (USPC1)
hsa-miR-210-3p Imatinib 5291 NSC743414 approved sensitive Low Chronic Myelogenous Leukemia tissue
hsa-miR-210-3p Dabrafenib 44462760 NSC764134 approved resistant High Melanoma cell line (A375)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant Low Renal Cell Cancer tissue
hsa-miR-210-3p Temozolomide 5394 NSC362856 approved resistant Low Glioma cell line (U87)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive High Hypopharyngeal Cancer cell line (FaDu)
hsa-miR-210-3p Platinum 23939 resistant High High-Grade Serous Ovarian Cancer tissue
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive Low Breast Cancer cell line (MCF-7)
hsa-miR-210-3p Sorafenib 216239 NSC747971 approved resistant High Hepatocellular Carcinoma cell line (PLC/PRF5-R1, PLC/PRF5-R2, PLC/PRF5)
hsa-miR-210-3p Gefitinib 123631 NSC715055 approved sensitive cell line (HCC827)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (A375)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (total RNA)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (CAL-27) (mitochondrial RNA)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (451Lu)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved sensitive cell line (A549)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKVO3ip1)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (HeyA8)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM17)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved sensitive cell line (LM11)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM43)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM47)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved sensitive cell line (HS578T)
hsa-miR-210-3p Doxorubicin 31703 NSC123127 approved resistant cell line (BAS)
hsa-miR-210-3p Tamoxifen+Fulvestrant sensitive cell line (LCC9)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (CIS)
hsa-miR-210-3p Exemestane 60198 NSC713563 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone 6013 NSC9700 approved resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Exemestane resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Letrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Anastrozole resistant cell line (MCF-7)
hsa-miR-210-3p Testosterone+Tamoxifen resistant cell line (MCF-7)
hsa-miR-210-3p Osimertinib 71496458 NSC779217 approved sensitive cell line (H1975)
hsa-miR-210-3p Methotrexate 126941 NSC740 approved resistant cell line (HT29)
hsa-miR-210-3p Fluorouracil 3385 NSC19893 approved resistant cell line (KM12C) (72 h)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (RPMI2650)
hsa-miR-210-3p Sunitinib 5329102 NSC750690 approved resistant tissue (CardA)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved resistant cell line (SKOV3)
hsa-miR-210-3p Platinum 23939 resistant tissue (non-small cell lung cancer)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR4)
hsa-miR-210-3p Tamoxifen 2733525 NSC180973 approved resistant cell line (TamR8)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR20)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR200)
hsa-miR-210-3p Paclitaxel 36314 NSC125973 approved sensitive cell line (PC3PR70)
hsa-miR-210-3p Vemurafenib 42611257 NSC761431 approved resistant cell line (LM16)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (100 nM)
hsa-miR-210-3p Bortezomib 387447 NSC681239 approved sensitive cell line (CCRF-CEM) (200 nM)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (100 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (PANC-1) (1500 ng/ml)
hsa-miR-210-3p Gemcitabine 60750 NSC613327 approved sensitive cell line (Panc1-GR1)
hsa-miR-210-3p Ceritinib 57379345 NSC776422 approved resistant cell line (H3122)
hsa-miR-210-3p Cisplatin 5460033 NSC119875 approved resistant cell line (H23)
hsa-miR-210-3p Cetuximab sensitive tissue (colorectal carcinoma)

Error report submission